U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840691) titled 'A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations' on Feb. 16.
Brief Summary: The purpose of this study is to investigate whether PEG-rhGH with new preparation is bioequivalent to PEG-rhGH with present preparation.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Pediatric Growth Hormone Deficiency (PGHD)
Intervention:
DRUG: PEG-rhGH with new preparation (T)
A single subcutaneous injection of PEG-rhGH with new preparation
DRUG: PEG-rhGH with present preparation (T)
A single subcutaneous injection of PEG-rhGH with present preparation
Recruitment Status: NOT_YET_RECRUITING
Sponsor: ...